Marshall Wace, LLP Johnson & Johnson Put Options Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $1.06 Million - $1.16 Million	-7,300 Reduced 6.49%	105,100 $16.5 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $2.59 Million - $2.9 Million	-16,600 Reduced 12.87%	112,400 $17.5 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $4 Million - $4.3 Million	25,900 Added 25.12%	129,000 $21.4 Million
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $23.9 Million - $28.6 Million	-158,400 Reduced 60.57%	103,100 $16 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $23.7 Million - $26.6 Million	147,800 Added 129.99%	261,500 $46.2 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $18.3 Million - $20.4 Million	113,700 New	113,700 $18.6 Million
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $17.9 Million - $19.9 Million	110,700 New	110,700 $17.9 Million

4,258

1.68B

16.1M

13.8M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $397B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.